Statement of Ownership (sc 13g)
January 20 2021 - 6:16AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
13G
Under
the Securities Exchange Act of 1934
(Amendment
No. ___)*
Microbot
Medical Inc.
|
(Name
of Issuer)
|
|
Common
Stock
|
(Title
of Class of Securities)
|
|
59503A204
|
(CUSIP
Number)
|
|
01/01/2021
|
(Date
of Event which Requires Filing of this Statement)
|
Check
the appropriate box to designate the rule pursuant to which this Schedule is filed:
|
[X]
Rule 13d-1(b)
|
|
|
|
[_]
Rule 13d-1(c)
|
|
|
|
[_]
Rule 13d-1(d)
|
*The
remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the
subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided
in a prior cover page.
The
information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section
18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the Notes).
SCHEDULE
13G
1
|
Names of Reporting
Persons
|
|
|
|
Chasing Value Asset
Management Inc. (TIN: 27-4574274)
|
2
|
Check the appropriate
box if a member of a Group (see instructions)
|
|
|
|
(a)
[ ]
(b)
[ ]
|
3
|
Sec Use Only
|
|
|
4
|
Citizenship or Place
of Organization
|
|
|
|
California
|
Number of
Shares
Beneficially
Owned by Each Reporting Person
With:
|
5
|
Sole Voting Power
|
207,000
|
6
|
Shared Voting Power
|
0
|
7
|
Sole Dispositive Power
|
610,657
|
8
|
Shared Dispositive Power
|
0
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
|
|
610,657
|
10
|
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
|
|
[ ]
|
11
|
Percent of class represented by amount in row (9)
|
|
8.6%
|
12
|
Type of Reporting Person (See Instructions)
|
|
IA
|
Item
1.
(a)
|
Name
of Issuer:
|
|
|
|
Microbot
Medical Inc.
|
|
|
(b)
|
Address
of Issuer’s Principal Executive Offices:
|
|
|
|
25
Recreation Park Drive, Unit 108
|
|
Hingham,
MA 02043
|
Item
2.
(a)
|
Name
of Person Filing:
|
|
|
|
Chasing
Value Asset Management, Inc.
|
|
|
(b)
|
Address
of Principal Business Office or, if None, Residence:
|
|
|
|
2444
Wilshire Boulevard, Suite 300
|
|
Santa
Monica, California 90403
|
|
|
(c)
|
Citizenship:
|
|
|
|
California,
USA
|
|
|
(d)
|
Title
and Class of Securities:
|
|
|
|
Common
Stock, par value $0.01
|
|
|
(e)
|
CUSIP
No.:
|
Item
3.
|
If
this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
|
(a)
|
[_]
|
Broker
or dealer registered under Section 15 of the Act;
|
|
|
|
|
|
(b)
|
[_]
|
Bank
as defined in Section 3(a)(6) of the Act;
|
|
|
|
|
|
(c)
|
[_]
|
Insurance
company as defined in Section 3(a)(19) of the Act;
|
|
|
|
|
|
(d)
|
[_]
|
Investment
company registered under Section 8 of the Investment Company Act of 1940;
|
|
|
|
|
|
(e)
|
[X]
|
An
investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
|
|
|
|
|
|
(f)
|
[_]
|
An
employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
|
|
|
|
|
|
(g)
|
[_]
|
A
parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
|
|
|
|
|
|
(h)
|
[_]
|
A
savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
|
|
|
|
(i)
|
[_]
|
A
church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company
Act of 1940;
|
|
|
|
|
|
(j)
|
[_]
|
A
non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J);
|
|
|
|
|
|
(k)
|
[_]
|
Group,
in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J),
please specify the type of institution: ____
|
(a)
|
Amount
Beneficially Owned:
|
|
|
|
610,657
|
|
|
(b)
|
Percent
of Class:
|
|
|
|
8.6%
|
(c)
|
Number of shares as to which such person has:
|
|
|
|
|
(i)
|
Sole
power to vote or to direct the vote:
|
|
|
|
|
|
207,000
|
|
|
|
|
(ii)
|
Shared
power to vote or to direct the vote:
|
|
|
|
|
|
0
|
|
|
|
|
(iii)
|
Sole
power to dispose or to direct the disposition of:
|
|
|
|
|
|
610,657
|
|
|
|
|
(iv)
|
Shared
power to dispose or to direct the disposition of:
|
|
|
|
|
|
0
|
Item
5.
|
Ownership
of Five Percent or Less of a Class.
|
If
this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial
owner of more than five percent of the class of securities, check the following [ ].
Item
6.
|
Ownership
of more than Five Percent on Behalf of Another Person.
|
Not
Applicable
Item
7.
|
Identification
and classification of the subsidiary which acquired the security being reported on by the parent holding company or control
person.
|
Not
Applicable
Item
8.
|
Identification
and classification of members of the group.
|
Not
Applicable
Item
9.
|
Notice
of Dissolution of Group.
|
Not
Applicable
By
signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are
held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing
or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant
in any transaction having that purpose or effect.
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Dated:
January 20, 2021
Chasing
Value Asset Management, Inc.
By:
|
/s/
Sheldon D. Liber
|
|
Name:
|
Sheldon
D. Liber
|
|
Title:
|
Chief
Executive Officer
|
|
Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Microbot Medical (NASDAQ:MBOT)
Historical Stock Chart
From Sep 2023 to Sep 2024